Literature DB >> 417754

Prevention of secondary cases of meningococcal disease in household contacts by vaccination.

B M Greenwood, M Hassan-King, H C Whittle.   

Abstract

Household contacts of patients with group A meningococcal infection were vaccinated with either meningococcal vaccine or tetanus toxoid. Five of the 523 subjects who received tetanus toxoid developed meningococcal meningitis and another four probably had meningococcal disease. Only one possible case of meningococcal infection occurred among 520 contacts vaccinated with meningococcal vaccine. Vaccination had no effect on nasopharyngeal carriage of meningococci. Vaccination of household contacts of patients with group A meningococcal infections is an effective way of using limited supplies of meningococcal vaccine, though its value would be limited in an epidemic. Secondary cases of meningococcal infection often occur within a few days of the index case, and, although vaccine alone seemed to provide adequate prophylaxis in these Nigerian subjects, additional chemoprophylaxis may be needed to cover this critical period.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 417754      PMCID: PMC1604678          DOI: 10.1136/bmj.1.6123.1317

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  A Severe Epidemic of Meningococcus Meningitis in Chile, 1941-1942.

Authors:  M Pizzi
Journal:  Am J Public Health Nations Health       Date:  1944-03

2.  Epidemiological Study of 383 Cases of Meningococcus Meningitis in the City of Milwaukee, 1927-1928 and 1929.

Authors:  M R French
Journal:  Am J Public Health Nations Health       Date:  1931-02

3.  An Epidemic of Cerebrospinal Meningitis in Saginaw, Mich.

Authors:  W H Pickett
Journal:  Am J Public Health Nations Health       Date:  1931-02

4.  The risk of meningitis among classroom contacts during an epidemic of meningococcal disease.

Authors:  J A Jacobson; P A Camargos; J T Ferreira; J B McCormick
Journal:  Am J Epidemiol       Date:  1976-11       Impact factor: 4.897

5.  Spread of meningococcal infection within households.

Authors:  R S Munford; A de E Taunay; J S de Morais; D W Fraser; R A Feldman
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

6.  Response of children to Neisseria meningitidis polysaccharide vaccines.

Authors:  A S Monto; B L Brandt; M S Artenstein
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

7.  Prophylaxis for meningococcal disease.

Authors:  M S Artenstein
Journal:  JAMA       Date:  1975-03-10       Impact factor: 56.272

8.  Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population.

Authors:  A B Kaiser; C H Hennekens; M S Saslaw; P S Hayes; J V Bennett
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

9.  Immunogenicity of the group A and group C meningococcal polysaccharides in children.

Authors:  I Goldschneider; M L Lepow; E C Gotschlich
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

10.  An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki area (Finland). Epidemiological and clinical observations.

Authors:  I Salmi; O Pettay; I Simula; A K Kallio; O Waltimo
Journal:  Scand J Infect Dis       Date:  1976
View more
  19 in total

Review 1.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review.

Authors:  M R Hoek; H Christensen; W Hellenbrand; P Stefanoff; M Howitz; J M Stuart
Journal:  Epidemiol Infect       Date:  2008-06-18       Impact factor: 2.451

3.  Failure of chemoprophylaxis to prevent meningococcal disease.

Authors:  G Foster; H Panigrahi; M Walker
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-29

4.  Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.

Authors:  Matthew J Ferrari; Florence Fermon; Fabienne Nackers; Augusto Llosa; Claire Magone; Rebecca F Grais
Journal:  Int Health       Date:  2014-09-05       Impact factor: 2.473

5.  Control of meningococcal epidemics.

Authors:  H Peltola
Journal:  Indian J Pediatr       Date:  1987 Mar-Apr       Impact factor: 1.967

6.  Carriage of Neisseria meningitidis: investigations in a military establishment.

Authors:  J V Pether; N F Lightfoot; R J Scott; J Morgan; A P Steele-Perkins; S C Sheard
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

7.  Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.

Authors:  J Zoe Jordens; Jeannette N Williams; Graeme R Jones; Myron Christodoulides; John E Heckels
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

8.  Mycoplasma pneumoniae and the aetiology of lobar pneumonia in northern Nigeria.

Authors:  J T Macfarlane; D S Adegboye; M J Warrell
Journal:  Thorax       Date:  1979-12       Impact factor: 9.139

9.  Clusters of meningococcal disease in France (1987-1988).

Authors:  R Olivares; B Hubert
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

10.  Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.

Authors:  Hani Jokhdar; Ray Borrow; Abdulrazaq Sultan; Mousaed Adi; Christine Riley; Emily Fuller; David Baxter
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.